Enzymotec Shareholders Approve Proposed Acquisition by Frutarom
11 déc. 2017 17h15 HE
|
Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...
Enzymotec Ltd. Reports Third Quarter 2017 Unaudited Financial Results
15 nov. 2017 07h35 HE
|
Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products,...
Enzymotec Ltd. Calls 2017 Annual and Extraordinary General Meeting of Shareholders for Approval of Merger and Other Matters
02 nov. 2017 08h15 HE
|
Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (the “Company”), today announced that it will hold its 2017 Annual and Extraordinary General Meeting of...
Enzymotec Enters Definitive Agreement to be Acquired by Frutarom
29 oct. 2017 00h00 HE
|
Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, Oct. 29, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products,...
Enzymotec Ltd. Expands VAYA Product Portfolio with Five Nutritional Supplements Acquired from Union Springs Healthcare
30 août 2017 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional...
Enzymotec Ltd. Responds to Unsolicited Proposal from Frutarom Ltd.
28 août 2017 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) today responded to the unsolicited proposal from Frutarom Ltd. to acquire Enzymotec for $11.50 per share by...
Enzymotec Ltd. Reports Second Quarter 2017 Unaudited Financial Results
16 août 2017 07h30 HE
|
Enzymotec Ltd.
Record INFAT® Net Revenues of $13.3 Million (Proportionate Consolidation Method) Generated Strong Cash Flow from Operations of $2.9 Million Inventory Write-Off of $3.3 Million MIGDAL HA'EMEQ,...
Enzymotec Ltd. Announces Appointment of Dror Israel as Chief Financial Officer
28 juil. 2017 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid based...
Enzymotec to Report Second Quarter 2017 Financial Results
26 juil. 2017 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 26, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...
Enzymotec Chief Financial Officer to Step Down
28 juin 2017 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, June 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...